His responsibilities cover the full spectrum of general obstetrics and gynecology on consultant level with special interest and experience in gynecologic oncology including radical surgery. He did clinical research in high risk obstetrics with special reference to pre-eclampsia and operative delivery. Obstetric and gynecologic aspects of thrombophilia are major areas of his current research interest. As clinical investigator, he contributed to several phase 2 and 3 international pharmaceutical projects including Epirubicin for ovarian cancer (Farmitalia), Provera for endometrial cancer (UpJohn), Diflucan for vaginal candidiasis (Pfizer), Synarel for endometriosis (Syntex), Taxol+Carboplatin for ovarian cancer (Bristol Myers), Mycosyst-Gyno for vaginal candidiasis (Richter), Basedoxifen (Wyeth).